A Trial of HRS-3095 in Healthy Volunteers

Recruiting now · Early Phase 1 · Has a placebo group

Conditions studied: Chronic Spontaneous Urticaria

In brief

The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

Key facts

Study ID

NCT07686484

Run by

Atridia Pty Ltd.

People needed

36

Starts

2026-07-27

Expected to finish

2026-10-15

Last updated by the study team

2026-08-07

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Veritus Research — Bayswater, Victoria, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.